On the occasion of World Hepatitis Day (#WHD), observed annually on July 28, Tianlong and KHB are leading initiatives focused on the early diagnosis, detection, and treatment of hepatitis, including #HBV, #HCV, #HAV, and #HEV.
Tianlong’s HBV Nucleic Acid Detection Kit is designed for in vitro quantitative detection of HBV and can assess the response and effectiveness of antiviral therapy by monitoring HBV levels. The kit offers precise and highly sensitive results, with the following specifications:
- Limit of Detection (LoD): 5 IU/mL
- Limit of Quantification (LoQ): 15 IU/mL
- Linear Range: 15-10^9 IU/mL
Let us work together to establish a world free from the burden of hepatitis by leveraging advanced diagnostics and proactive healthcare approaches. Together, we can significantly impact the global effort against hepatitis.
